Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG
about
Animal models to study Mycobacterium tuberculosis and HIV co-infectionMonkey models of tuberculosis: lessons learnedA critical role for CD8 T cells in a nonhuman primate model of tuberculosis.Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cellsImmune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaquesTCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria.Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.SIV Infection Facilitates Mycobacterium tuberculosis Infection of Rhesus Macaques.The non-human primate model of tuberculosis.CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment.Translational Research in the Nonhuman Primate Model of Tuberculosis.Clinical latency and reactivation of AIDS-related mycobacterial infectionsAdaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections.Immune biology of macaque lymphocyte populations during mycobacterial infection.
P2860
Q26824653-A5FD51A1-DCC9-45BE-BEA1-A0F89AE739CDQ28081586-623E18CC-D079-4D2E-BC81-F0D532659103Q33432697-55FCF22C-74B5-4BDC-A4A8-10A1137F3CE5Q33832302-6E5062F8-8E17-49B7-8C37-B27B2AF1908AQ33914191-A4090E2B-CF7D-414A-8B52-1DA9FB54E370Q34159662-47242C6D-B499-436D-8F9F-174C73155B43Q35135987-D70E1675-8BF1-4229-828D-F6D011DF385CQ36154750-F7AEC164-0958-45D0-A589-4A10F196CB27Q36650810-2F3E8D9F-F183-497C-921B-3980E08A291BQ36936342-90E76C9F-3000-409E-962B-25EC5EAC5854Q37334816-9E74A4A3-99FA-4E9E-8050-66D56471F24DQ37583972-4D6C2A56-BAC5-4703-9945-59DAF61F1D57Q37652734-00479D61-2EBF-4557-B54C-1E8FA5020543Q37730097-1AFB627E-AAA2-4EFC-BBEA-74686D3B3E3EQ40175400-7C79A357-B097-4942-940B-D53C137DAFDFQ40584247-E1D785A6-8DFD-4EA5-AEB0-143FEEA053C1Q40622705-7B5F2D08-E9F6-483C-8EE5-829639660B4BQ52006686-2945AA17-4DA3-4A12-A794-BC5BF97E506E
P2860
Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Antiretroviral agents restore ...... us and Mycobacterium bovis BCG
@en
Antiretroviral agents restore ...... s and Mycobacterium bovis BCG.
@nl
type
label
Antiretroviral agents restore ...... us and Mycobacterium bovis BCG
@en
Antiretroviral agents restore ...... s and Mycobacterium bovis BCG.
@nl
prefLabel
Antiretroviral agents restore ...... us and Mycobacterium bovis BCG
@en
Antiretroviral agents restore ...... s and Mycobacterium bovis BCG.
@nl
P2093
P2860
P921
P1433
P1476
Antiretroviral agents restore ...... us and Mycobacterium bovis BCG
@en
P2093
B Henckler
L Chalifoux
N L Letvin
P2860
P304
P356
10.1128/JVI.75.18.8690-8696.2001
P407
P577
2001-09-01T00:00:00Z